Is there a role for the use of IFN-α in primary myelofibrosis?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 567-570

  Nguyen, Huong Marie ^a   Kiladjian, Jean Jacques ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; JAK2 PROTEIN, HUMAN; JANUS KINASE 2;

BIOPSY; BONE MARROW; BONE MARROW CELL; CASE REPORT; CLINICAL TRIAL (TOPIC); CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEMATOLOGY; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; MYELOID METAPLASIA; PATHOLOGY; REVIEW;

BIOPSY; BONE MARROW; BONE MARROW CELLS; CLINICAL TRIALS AS TOPIC; HEMATOLOGY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; PRIMARY MYELOFIBROSIS;

MLCS; MLOWN;

EID: 84879354085     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.567.3806899     Document Type: Review

References (0)